Siemens Healthineers AG (0PMJ.L)
EUR 45.76
(2.33%)
EUR 45.76
(2.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 22.36 Billion EUR | 3.15% |
| 2023 | 21.68 Billion EUR | -0.16% |
| 2022 | 21.71 Billion EUR | 20.65% |
| 2021 | 17.99 Billion EUR | 24.46% |
| 2020 | 14.46 Billion EUR | -0.4% |
| 2019 | 14.51 Billion EUR | 8.11% |
| 2018 | 13.42 Billion EUR | -2.66% |
| 2017 | 13.79 Billion EUR | 1.84% |
| 2016 | 13.54 Billion EUR | 4.72% |
| 2015 | 12.93 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.43 Billion EUR | 5.0% |
| 2024 Q1 | 5.17 Billion EUR | -14.53% |
| 2024 Q3 | 5.42 Billion EUR | -0.22% |
| 2023 FY | 21.68 Billion EUR | -0.16% |
| 2023 Q3 | 5.2 Billion EUR | -2.71% |
| 2023 Q4 | 6.05 Billion EUR | 16.44% |
| 2023 Q1 | 5.07 Billion EUR | -15.38% |
| 2023 Q2 | 5.34 Billion EUR | 5.3% |
| 2022 Q1 | 5.06 Billion EUR | -1.86% |
| 2022 Q4 | 6 Billion EUR | 15.7% |
| 2022 Q3 | 5.18 Billion EUR | -5.02% |
| 2022 Q2 | 5.46 Billion EUR | 7.73% |
| 2022 FY | 21.71 Billion EUR | 20.65% |
| 2021 Q1 | 3.86 Billion EUR | -0.21% |
| 2021 FY | 17.99 Billion EUR | 24.46% |
| 2021 Q4 | 5.16 Billion EUR | 3.28% |
| 2021 Q3 | 5 Billion EUR | 26.1% |
| 2021 Q2 | 3.96 Billion EUR | 2.51% |
| 2020 Q1 | 3.58 Billion EUR | -13.4% |
| 2020 FY | 14.46 Billion EUR | -0.4% |
| 2020 Q2 | 3.68 Billion EUR | 2.73% |
| 2020 Q4 | 3.87 Billion EUR | 17.03% |
| 2020 Q3 | 3.31 Billion EUR | -10.12% |
| 2019 Q4 | 4.14 Billion EUR | 16.05% |
| 2019 Q3 | 3.56 Billion EUR | 1.8% |
| 2019 Q2 | 3.5 Billion EUR | 6.21% |
| 2019 Q1 | 3.3 Billion EUR | -10.88% |
| 2019 FY | 14.51 Billion EUR | 8.11% |
| 2018 Q4 | 3.7 Billion EUR | 12.24% |
| 2018 FY | 13.42 Billion EUR | -2.66% |
| 2018 Q3 | 3.3 Billion EUR | 2.29% |
| 2018 Q2 | 3.22 Billion EUR | 0.88% |
| 2018 Q1 | 3.19 Billion EUR | -15.08% |
| 2017 Q1 | 3.32 Billion EUR | 0.0% |
| 2017 FY | 13.79 Billion EUR | 1.84% |
| 2017 Q3 | 3.3 Billion EUR | -2.62% |
| 2017 Q2 | 3.39 Billion EUR | 2.07% |
| 2017 Q4 | 3.76 Billion EUR | 13.88% |
| 2016 FY | 13.54 Billion EUR | 4.72% |
| 2015 FY | 12.93 Billion EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | -3530.387% |
| Guerbet SA | 795.65 Million EUR | -2710.644% |
| Nexus AG | 241.45 Million EUR | -9161.614% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | -4121.385% |
| Revenio Group Oyj | 96.57 Million EUR | -23055.857% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | -562.901% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | -558.568% |
| LNA Santé SA | 736.08 Million EUR | -2938.1% |
| Medios AG | 1.78 Billion EUR | -1153.038% |
| Equasens Société anonyme | 219.78 Million EUR | -10074.805% |
| Stratec SE | 261.91 Million EUR | -8438.397% |